Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases

被引:5
|
作者
Werensteijn-Honingh, Anita M. [1 ]
Kroon, Petra S. [1 ]
Winkel, Dennis [1 ]
van Gaal, J. Carlijn [1 ]
Hes, Jochem [1 ]
Snoeren, Louk M. W. [1 ]
Timmer, Jaleesa K. [1 ]
Mout, Christiaan C. P. [1 ]
Bol, Gijsbert H. [1 ]
Kotte, Alexis N. [1 ]
Eppinga, Wietse S. C. [1 ]
Intven, Martijn [1 ]
Raaymakers, Bas W. [1 ]
Jurgenliemk-Schulz, Ina M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiotherapy, HP Q00-3-11,POB 85500, NL-3508 GA Utrecht, Netherlands
关键词
Bowel; Duodenum; MR-linac; CBCT-linac; Stereotactic body radiotherapy; Lymph node metastases; RADIATION-THERAPY; ADAPTIVE RADIOTHERAPY; SBRT; FEASIBILITY; MOTION;
D O I
10.1016/j.phro.2022.06.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Magnetic resonance (MR)-linac delivery is expected to improve organ at risk (OAR) sparing. In this study, OAR doses were compared for online adaptive MR-linac treatments and conventional cone beam computed tomography (CBCT)-linac radiotherapy, taking into account differences in clinical workflows, especially longer session times for MR-linac delivery.Materials and methods: For 25 patients with pelvic/abdominal lymph node oligometastases, OAR doses were calculated for clinical pre-treatment and daily optimized 1.5 T MR-linac treatment plans (5 x 7 Gy) and compared with simulated CBCT-linac plans for the pre-treatment and online anatomical situation. Bowelbag and duodenum were re-contoured on MR-imaging acquired before, during and after each treatment session. OAR hard constraint violations, D0.5cc and D10cc values were evaluated, focusing on bowelbag and duodenum.Results: Overall, hard constraints for all OAR were violated less often in daily online MR-linac treatment plans compared with CBCT-linac: in 5% versus 22% of fractions, respectively. D0.5cc and D10cc values did not differ significantly. When taking treatment duration and intrafraction motion into account, estimated delivered doses to bowelbag and duodenum were lower with CBCT-linac if identical planning target volume (PTV) margins were used for both modalities. When reduced PTV margins were achievable with MR-linac treatment, bowelbag doses were lower compared with CBCT-linac. Conclusions: Compared with CBCT-linac treatments, the online adaptive MR-linac approach resulted in fewer hard planning constraint violations compared with single-plan CBCT-linac delivery. With respect to other bowelbag/duodenum dose-volume parameters, the longer duration of MR-linac treatment sessions negatively impacts the potential dosimetric benefit of daily adaptive treatment planning.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 50 条
  • [21] Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer
    Tai Ermongkonchai
    Richard Khor
    Vijayaragavan Muralidharan
    Niall Tebbutt
    Kelvin Lim
    Numan Kutaiba
    Sweet Ping Ng
    World Journal of Gastroenterology, 2022, (07) : 745 - 754
  • [22] Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
    Burkon, Petr
    Selingerova, Iveta
    Slavik, Marek
    Pospisil, Petr
    Bobek, Lukas
    Kominek, Libor
    Osmera, Pavel
    Prochazka, Tomas
    Vrzal, Miroslav
    Kazda, Tomas
    Slampa, Pavel
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [23] Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
    Weykamp, Fabian
    Hoegen, Philipp
    Klueter, Sebastian
    Spindeldreier, C. Katharina
    Koenig, Laila
    Seidensaal, Katharina
    Regnery, Sebastian
    Liermann, Jakob
    Rippke, Carolin
    Koerber, Stefan A.
    Buchele, Carolin
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution
    Hoegen-Sassmannshausen, Philipp
    Jessen, Inga
    Buchele, Carolin
    Schlueter, Fabian
    Rippke, Carolin
    Renkamp, Claudia Katharina
    Weykamp, Fabian
    Regnery, Sebastian
    Liermann, Jakob
    Meixner, Eva
    Hoeltgen, Line
    Eichkorn, Tanja
    Koenig, Laila
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2024, 16 (12)
  • [25] Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: Initial clinical experience and patient-reported outcomes
    Weykamp, F.
    Hoegen, P.
    Klueter, S.
    Renkamp, K.
    Konig, L.
    Seidensaal, K.
    Regnery, S.
    Liermann, J.
    Rippke, C.
    Koerber, S. A.
    Buchele, C.
    Debus, J.
    Hoerner-Rieber, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1017 - S1017
  • [26] Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient
    Boldrini, Luca
    Cellini, Francesco
    Manfrida, Stefania
    Chiloiro, Giuditta
    Teodoli, Stefania
    Cusumano, Davide
    Fionda, Bruno
    Mattiucci, Gian Carlo
    De Gaetano, Anna Maria
    Azario, Luigi
    Valentini, Vincenzo
    CUREUS, 2018, 10 (03):
  • [27] Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report
    Tyran, Marguerite
    Cao, Minsong
    Raldow, Ann C.
    Dang, Audrey
    Lamb, James
    Low, Daniel A.
    Steinberg, Michael L.
    Lee, Percy
    CUREUS, 2018, 10 (03):
  • [28] Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?
    Drabble, Joseph
    Das, Prantik
    George, Ben
    Camilleri, Philip
    Morris, Alex
    MEDICAL DOSIMETRY, 2022, 47 (04) : 334 - 341
  • [29] CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy
    Rodriguez, Lori L.
    Kotecha, Rupesh
    Tom, Martin C.
    Chuong, Michael D.
    Contreras, Jessika A.
    Romaguera, Tino
    Alvarez, Diane
    McCulloch, James
    Herrera, Robert
    Hernandez, Rene J.
    Mercado, Jairo
    Mehta, Minesh P.
    Gutierrez, Alonso N.
    Mittauer, Kathryn E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 166 : 101 - 109
  • [30] Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
    Darren M. C. Poon
    Bin Yang
    Hui Geng
    Oi Lei Wong
    Sin Ting Chiu
    Kin Yin Cheung
    Siu Ki Yu
    George Chiu
    Jing Yuan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 841 - 850